MedTrace Logo

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

NCT02735499 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2018-11-26

No results posted yet for this study

Summary

Instillation treatment with onabotulinumtoxin A (BOTOX®) in the urinary bladder

Conditions

Interventions

DRUG

onabotulinum toxin A

Onabotulinum toxin A is installed into the bladder and EMDA (Electromotive Drug Application) is applied for 30 minutes

Sponsors & Collaborators

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER

  • The Hospital of Vestfold

    lead OTHER

Principal Investigators

  • Hjalmar A Schiotz, MD, PhD · Vestfold Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02735499 on ClinicalTrials.gov